Shamim Ruff
2016
In 2016, Shamim Ruff earned a total compensation of $2M as Senior Vice President, Regulatory Affairs and Quality at Sarepta Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $170,914 |
|---|---|
| Option Awards | $596,305 |
| Salary | $356,070 |
| Stock Awards | $877,217 |
| Other | $15,567 |
| Total | $2,016,073 |
Ruff received $877.2K in stock awards, accounting for 44% of the total pay in 2016.
Ruff also received $170.9K in non-equity incentive plan, $596.3K in option awards, $356.1K in salary and $15.6K in other compensation.
Rankings
In 2016, Shamim Ruff's compensation ranked 4,851st out of 14,075 executives tracked by ExecPay. In other words, Ruff earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,851 out of 14,075 | 66th |
Division Manufacturing | 1,728 out of 5,488 | 69th |
Major group Chemicals And Allied Products | 539 out of 1,900 | 72nd |
Industry group Drugs | 398 out of 1,543 | 74th |
Industry Pharmaceutical Preparations | 316 out of 1,173 | 73rd |
Source: SEC filing on April 27, 2017.
Ruff's colleagues
We found four more compensation records of executives who worked with Shamim Ruff at Sarepta Therapeutics in 2016.